These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16932460)

  • 21. Is it time to stop treating dyslipidaemia with fibrates?
    Benatar JR; Stewart RA
    N Z Med J; 2007 Sep; 120(1261):U2706. PubMed ID: 17853928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis.
    Robinson JG
    N Engl J Med; 2005 Oct; 353(17):1858-60; author reply 1858-60. PubMed ID: 16252415
    [No Abstract]   [Full Text] [Related]  

  • 23. Charting new territory by simulated modeling of a clinical trial.
    Tuttle KR
    Clin J Am Soc Nephrol; 2010 May; 5(5):750-2. PubMed ID: 20360306
    [No Abstract]   [Full Text] [Related]  

  • 24. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
    Shepherd J; Kastelein JJ; Bittner V; Deedwania P; Breazna A; Dobson S; Wilson DJ; Zuckerman A; Wenger NK;
    J Am Coll Cardiol; 2008 Apr; 51(15):1448-54. PubMed ID: 18402899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study.
    Renke M; Tylicki L; Rutkowski P; Neuwelt A; Larczyński W; Ziętkiewicz M; Aleksandrowicz E; Lysiak-Szydłowska W; Rutkowski B
    Acta Biochim Pol; 2010; 57(4):547-52. PubMed ID: 21079818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD; Rattinger GB; Kuznik A; Koren MJ
    Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study.
    Wenger NK; Lewis SJ; Welty FK; Herrington DM; Bittner V;
    Heart; 2008 Apr; 94(4):434-9. PubMed ID: 18070940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ARMYDA trials (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) at Campus Bio-Medico University: rationale, results and future horizons.
    di Sciascio G
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():41-3. PubMed ID: 18001321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of atorvastatin on carotid intima media thickness: a meta-analysis of randomized controlled trials.
    Takagi H; Yamamoto H; Iwata K; Goto SN; Umemoto T
    Int J Cardiol; 2012 Aug; 159(1):69-72. PubMed ID: 22575629
    [No Abstract]   [Full Text] [Related]  

  • 30. Battle of the statins, or how the news media can change patient care.
    Hegmann T
    JAAPA; 2004 Jan; 17(1):9-11. PubMed ID: 15307332
    [No Abstract]   [Full Text] [Related]  

  • 31. Statins and CVD prevention in the diabetic population: implications of the CARDS trial.
    Murad O; Palmer J; Sowers J; McFarlane SI
    Curr Diab Rep; 2005 Jun; 5(3):191-3. PubMed ID: 15929865
    [No Abstract]   [Full Text] [Related]  

  • 32. ASCOT-LLA: questions about the benefits of atorvastatin.
    Ravnskov U
    Lancet; 2003 Jun; 361(9373):1986; author reply 1986-7. PubMed ID: 12801761
    [No Abstract]   [Full Text] [Related]  

  • 33. Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?
    Krane V; Wanner C
    Am J Kidney Dis; 2005 Mar; 45(3):607-9. PubMed ID: 15754285
    [No Abstract]   [Full Text] [Related]  

  • 34. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
    Dogra G; Irish A; Chan D; Watts G
    Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ASCOT analysis with atorvastatin shows limits of CRP as indicator of cardiovascular risk.
    Cardiovasc J Afr; 2011; 22(1):51. PubMed ID: 21298210
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
    Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
    Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
    LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
    Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol.
    Bergheanu SC; Van Tol A; Dallinga-Thie GM; Liem A; Dunselman PH; Van der Bom JG; Jukema JW
    Curr Med Res Opin; 2007 Sep; 23(9):2235-40. PubMed ID: 17692153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk.
    Blanco-Colio LM; Martín-Ventura JL; Gómez-Guerrero C; Masramon X; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Egido J
    Eur J Pharmacol; 2008 May; 586(1-3):259-65. PubMed ID: 18374327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): response to Server et al.
    Tseng KH
    Diabetes Care; 2005 Oct; 28(10):2595; author reply 2595-6. PubMed ID: 16186315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.